About Zenara
Zenara is a company based in Hyderabad (India) founded in 2004 was acquired by Cambrex in November 2010. The company has 231 employees as of May 31, 2025. Zenara offers products and services including Oral Solids, Liquids, and Parenteral Formulations. Zenara operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Hyderabad, India
- Employees 231 as on 31 May, 2025
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zenara Pharma India Private Limited
- Date of Incorporation 02 Jul, 2004
- Jurisdiction Mumbai, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zenara
Zenara offers a comprehensive portfolio of products and services, including Oral Solids, Liquids, and Parenteral Formulations.
Produces solid medications for global distribution.
Manufactures liquid formulations for healthcare needs.
Develops injectable drugs for medical applications.
Funding Insights of Zenara
Detailed funding history for Zenara
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Zenara
Zenara has secured backing from 1 investor. Prominent investors backing the company include Cambrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO of complex small molecule APIs, including highly potent APIs
|
Locked | Locked | Locked |
Investor details for Zenara
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zenara
Investment portfolio details for Zenara
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zenara
Detailed financials for Zenara
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zenara Comparisons
Peer comparison for Zenara
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zenara
Zenara operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oral solid drug delivery systems are manufactured and developed.
|
|
| Locked | Locked | Locked |
Solid and semisolid dosage forms are developed and manufactured.
|
|
| Locked | Locked | Locked |
Company developing small molecules & eukaryotic cell based recombinant protein drugs
|
|
| Locked | Locked | Locked |
Dosage forms are delivered for preclinical, clinical, and commercial supply.
|
|
| Locked | Locked | Locked |
CDMO manufacturing solid drugs
|
|
| Locked | Locked | Locked |
Product development, manufacturing and packaging services
|
Detailed competitors of Zenara
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zenara
Complete news archive for Zenara
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zenara
Zenara was founded in 2004.
Zenara is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Srinivas Arutla is the current CEO of Zenara.
As of May 31, 2025, the latest employee count at Zenara is 231.
Annual revenue of Zenara is $4.99M as on Mar 31, 2022.
Zenara was established in 2004 in Hyderabad, India, as a contract development and manufacturing organization within the pharmaceutical sector. Formulation development, manufacturing, and technology transfers for solid oral dosage forms are handled by the company. Nicotine Replacement Therapy products, such as medicated chewing gums and lozenges, are also developed and supplied. Operations are conducted as a wholly owned subsidiary of Cambrex, with a focus on regulatory services and licensing.
Zenara's top competitors include Inventia Healthcare, Zim Labs and Lotus.
Zenara offers Oral Solids, Liquids, and Parenteral Formulations.
Zenara has 1 investor. Key investors include Cambrex.